Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of MT10109 vs Botox in Cervical Dystonia
NCT01588574Phase 2Completed
- Sponsor
- Medytox Inc.
- Start
- Aug 2012
- Primary completion
- Oct 2013
- Modality
- Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of nivobotulinumtoxinA in cervical dystonia (CD), sponsored by Medytox Inc.. Started Aug 2012; status: completed.
02
Drugs
nivobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT01588574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588574.